PCM
BMRA icon

Potomac Capital Management’s Biomerica BMRA Stock Holding History

Potomac Capital Management’s Portfolio BMRA Stock Details BMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$210K Sell
20,963
-477
-2% -$3.61K 0.24% 47
2023
Q3 		$148K Sell
21,440
-28,925
-57% -$287K 0.19% 46
2023
Q2 		$548K Sell
50,365
-3,656
-7% -$43.3K 0.56% 40
2023
Q1 		$808K Buy
+54,021
New +$1.16M 0.85% 36

Other funds holding BMRA

GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Potomac Capital Management's BMRA Position: Q4 2023 in Review

Potomac Capital Management reduced its Biomerica (BMRA) stake by 2.2% in Q4 2023, selling an estimated $3.61K and leaving 20,963 shares worth $210K. The position accounts for 0.24% of the portfolio, ranked #47.

Potomac Capital Management first reported a position in BMRA in Q1 2023 and has held it in 4 quarters since. The position peaked at $808K in Q1 2023. 33 funds tracked by Wall St. Rank hold BMRA as of Q4 2023.

  • Potomac Capital Management held 20,963 shares of Biomerica worth $210K as of Q4 2023.
  • Potomac Capital Management sold 477 Biomerica shares in Q4 2023, an estimated $3.61K.
  • Biomerica made up 0.24% of Potomac Capital Management's portfolio in Q4 2023, its #47 holding.
  • Potomac Capital Management first reported a position in Biomerica in Q1 2023 and has held it in 4 quarters since.
  • Potomac Capital Management's Biomerica position peaked at $808K in Q1 2023.
  • 33 funds tracked by Wall St. Rank held Biomerica as of Q4 2023.

Based on Potomac Capital Management's 13F filing for Q4 2023, filed 15 Feb 2024.